JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

New findings on the effects of diabetes and anti-diabetic drugs on prostate cancer

  • 0Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul, Republic of Korea.
American Journal of Cancer Research +

|

December 11, 2024

|

December 11, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Diabetes mellitus (DM) and hyperglycemia show an inverse relationship with prostate cancer (PC) risk. Specific glycemic statuses and anti-diabetic drugs may further modify this association, warranting further investigation.

Area Of Science

  • Endocrinology
  • Oncology
  • Epidemiology

Background

  • Diabetes mellitus (DM) is linked to various cancers.
  • Limited research exists on the association between hyperglycemia, prediabetes, and prostate cancer (PC) risk.
  • Understanding these relationships is crucial for cancer prevention and management.

Purpose Of The Study

  • To investigate the effect of hyperglycemia status, including prediabetes and DM, on PC risk.
  • To analyze the influence of metabolic syndrome components on PC risk across different glycemic statuses.
  • To evaluate the association between anti-diabetic drug use and PC incidence.

Main Methods

  • Analysis of a Korean National Health Insurance Service database cohort (560,413 individuals).
  • Evaluation of PC risk in patients with impaired fasting glucose (IFG) and new-onset/all DM.
  • Assessment of metabolic syndrome (MetS) components and anti-diabetic drug associations with PC risk.

Main Results

  • New-onset and all DM significantly reduced PC risk in adjusted models.
  • DM showed a trend of reduced PC risk, irrespective of MetS components.
  • DM patients using fewer than three oral hypoglycemic agents, including metformin, had reduced PC risk compared to non-users.

Conclusions

  • This study supports an inverse relationship between DM and PC risk.
  • Glycemic status and specific anti-diabetic medications may influence PC risk.
  • Further research is needed to clarify these nuanced associations.

Keywords:

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer 01:19

24

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Disorders of the Male Reproductive System 01:20

325

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Antihypertensive Drugs: Action of Diuretics 01:16

618

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...

Oral Hypoglycemic Agents: Biguanides and Glitazones 01:26

172

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System 01:26

385

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors 01:19

159

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...